Impact of Insulin Resistance, Body Mass Index, Disease Duration, and Duration of Metformin Use on the Efficacy of Vildagliptin

INTRODUCTION: The optimal stage for dipeptidyl peptidase-4 (DPP-4) inhibitor therapy in the course of type 2 diabetes mellitus (T2DM) is still under discussion, with often a perception that treatment with these agents may be less beneficial with increasing disease progression, due to loss of beta-ce...

Descripción completa

Detalles Bibliográficos
Autores principales: Schweizer, Anja, Dejager, Sylvie, Foley, James E.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Healthcare Communications 2012
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3508106/
https://www.ncbi.nlm.nih.gov/pubmed/22736406
http://dx.doi.org/10.1007/s13300-012-0008-5

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3508106/
https://www.ncbi.nlm.nih.gov/pubmed/22736406
http://dx.doi.org/10.1007/s13300-012-0008-5

Ejemplares similares